AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
AngioDynamics (ANGO) Tops Q3 EPS by 4c, Offers Guidance
March 30, 2021 7:03 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $71.2 million versus the consensus estimate of $68.95 million.
GUIDANCE:
AngioDynamics sees FY2021 EPS of $0.04-$0.06, versus the consensus of $0.01. AngioDynamics sees... More
